In a large Japanese birth cohort, cesarean delivery was not linked to higher risks of eczema, wheezing, atopic dermatitis, or ...

Conference call scheduled for November 13, 2025 at 8:00am ET Commercial launch of ZELSUVMI, the first FDA-approved at-home ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

You may bleed after giving birth, as your body heals. This bleeding is expected, but should not be too heavy. Heavy bleeding ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced that it has entered into a securities purchase agreement with a ...

Atea Pharmaceuticals, Inc. ( AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Jordan Feld Anthony Martinez Nancy Reau Eric ...

Operator: Good morning, and welcome to BiomX Third Quarter 2025 Financial Results and Program Update Conference Call.

Sauerkraut contains probiotics, vitamins, and fiber that offer benefits such as improved digestion, reduced inflammation, and ...

PolyPid Ltd. (NASDAQ: PYPD) Q3 2025 Earnings Call Transcript November 12, 2025 PolyPid Ltd. beats earnings expectations.

Investigational ZORYVE cream 0.05% was formulated for the delicate skin of infants and young children with mild to moderate atopic ...

Conference call scheduled for November 13, 2025 at 8:00am ET Commercial launch of ZELSUVMI, the first FDA-approved at-home molluscum contagiosum treatment, exceeded expectations and generated $7.1 mil ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single ...